|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 61.5 TWD | -0.81% |
|
+4.24% | -11.38% |
OBI Pharma, Inc. announced the change of financial officer. Name, title, and resume of the previous position holder: Frank Chen /CFO /Board member and CFO, OBI Pharma Inc. Name, title, and resume of the new position holder: Colin Kao /Director /Finance director, OBI Pharma Inc. Reason for the change: Position adjustment. Effective date: November 6, 2023.
The Board of Directors resolved to appoint Colin Kao as financial officer. Frank Chen will no longer serve as CFO.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.38% | 437M | |
| +25.69% | 47.9B | |
| +46.90% | 41.42B | |
| -3.46% | 40.7B | |
| -6.20% | 28.92B | |
| +9.17% | 25.55B | |
| -20.42% | 19.27B | |
| +0.17% | 12.15B | |
| +28.07% | 12.14B | |
| -1.24% | 11.99B |
OBI PHARMA, INC. 
